Pasar al contenido principal

CELULAS T ASOCIADAS A LA EDAD EN EL EJE INTESTINO-CEREBRO

PID2022-141169OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD4 T cell therapy counteracts inflammaging and senescence by preserving gut barrier integrity

  • Gómez de las Heras, Manuel M.
  • Carrasco, Elisa
  • Pérez-Manrique, Mario
  • Inohara, Naohiro
  • Delgado-Pulido, Sandra
  • Fernández-Almeida, Álvaro
  • Gálvez-Castaño, María I.
  • Francos-Quijorna, Isaac
  • Simó, Carolina
  • García-Cañas, Virginia
  • Escrig-Larena, Jose Ignacio
  • Aranda, Juan Francisco
  • Soto-Heredero, Gonzalo
  • Gabandé-Rodríguez, Enrique
  • Blanco, Eva M.
  • Días-Almeida, Joyce
  • Núñez, Gabriel
  • Mittelbrunn, María
Healthy aging relies on a symbiotic host–microbiota relationship. The age-associated decline of the immune system can pose a threat in this delicate equilibrium. In this work, we investigated how the functional deterioration of T cells can impact host–microbiota symbiosis and gut barrier integrity and the implications of this deterioration for inflammaging, senescence, and health decline. Using the Tfamfl/flCd4 Cre mouse model, we found that T cell failure compromised gut immunity leading to a decrease in T follicular and regulatory T (Treg) cells and an accumulation of highly proinflammatory and cytotoxic T cells. These alterations were associated with intestinal barrier disruption and gut dysbiosis. Microbiota depletion or adoptive transfer of total CD4 T cells or a Treg cell–enriched pool prevented gut barrier dysfunction and mitigated premature inflammaging and senescence, ultimately enhancing healthspan in this mouse model. Thus, a competent CD4 T cell compartment is critical to ensure healthier aging by promoting host–microbiota mutualism and gut barrier integrity., This research was supported by European Research Council grant ERC-2021-CoG 101044248-Let T Be (M.M.), Comunidad de Madrid (Spain) grant Y2020/BIO-6350 NutriSION-CM synergy (E.C. and M.M.), Spanish Ministerio de Ciencia e Innovación grant PID2022-141169OB-I00 (M.M.), Comunidad de Madrid (Spain) – Universidad Autónoma de Madrid (UAM) grant SI4/PJI/2024-00166 (E.C.), NIH grant R01 DK095782 (G.N.), Ministerio de Ciencia, Innovación y Universidades (Spain) FPU grants FPU19/02576 (M.M.G.H.), FPU22/01192 (M.P.-M.), and FPU20/04066 (J.I.E.-L.), Comunidad de Madrid (Spain) PIPF grant PIPF-2022/SAL-GL-25208 (S.D.-P.), Universidad Autónoma de Madrid FPI-UAM grant (G.S.-H.), and Ministerio de Ciencia, Innovación y Universidades (Spain) Juan de la Cierva-Incorporación grants IJC2018-036850-I (E.G.-R.) and JC2020-044392-I(I.F.-Q.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aging reshapes the adaptive immune system from healer to saboteur

  • Delgado-Pulido, Sandra
  • Yousefzadeh, Matthew J.
  • Mittelbrunn, Maria
The classical role of adaptive immunity as a protector against external threats has expanded to include its functions in cancer surveillance, tissue repair and regeneration, and, more recently, it has emerged as a regulator of the aging process. In this Perspective, we discuss the mechanisms by which the deterioration of adaptive immunity contributes to inflammaging, cellular senescence and age-associated pathologies. We propose that age-related changes in lymphocytes contribute to aging through two distinct mechanisms. First, adaptive immune function worsens with age, impairing immunosurveillance of damaged or senescent cells and diminishing tissue regenerative potential, thereby indirectly disrupting tissue homeostasis. This disruption is particularly important in the gut, where maintaining tissue and microbiota homeostasis is crucial for overall health during aging. Second, adaptive immune cells often acquire pro-inflammatory and autoaggressive phenotypes with age, directly driving tissue damage, promoting senescence and exacerbating inflammaging. Finally, we explore the therapeutic potential of strategies aimed at enhancing the protective functions of lymphocytes or modulating their pathogenic phenotypes to promote healthy aging., Funded by the European Union (M.M.). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This work was supported by the European Research Council (ERC-2021-CoG 101044248-Let T Be) (M.M.) and Spanish Ministerio de Ciencia e Innovación (PID2022-141169OB-I00) grants (M.M.), NIH grant R21AG087361 (M.J.Y.), a Nelson Family Transplant Innovation Award (M.J.Y.), pilot projects from the New York Nutrition and Obesity Research Center and the CALERIE study (M.J.Y.). S.D.-P. was supported by a PIPF grant (PIPF-2022/SAL-GL-25208) from the Comunidad de Madrid (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response

  • Rochano-Ortiz, Antonio
  • Simó, Carolina
  • García-Cañas, Virginia
  • Gabandé-Rodríguez, Enrique
  • Mittelbrunn, María
  • Oller, Jorge
Rochano-Ortiz et al., [Background and aims]: Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology., [Methods]: Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential., [Results]: Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model., [Conclusions]: The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I) and grant from Spanish Ministerio de Ciencia e Innovación grant (PID2022-137730OA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, EU; granted by Fundación MERCK-FEDER ‘Investigación clínica en enfermedades raras 2022’, Marfan Spanish Association (SIMA, www.Marfan.es) and by ‘V-Ayudas Muévete por los que no pueden 2021’. Research in M.M.’s lab was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). European Research Council. M.M.-L., G.A.-L., and G.A.-E. are funded by Instituto de Salud Carlos III through the projects PI20/01103, PI23/00100, and CP22/00100 (co-funded by European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future’). J.L.M.-V. is supported by grant from Spanish Ministerio de Ciencia e Innovación (PID2022-136979OB-I00). L.M.B.-C. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII/FEDER PI22/00233). G.T.-T. and A.G. are supported by Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015). O.L. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI20/00923 Instituto Carlos III). J.F.N. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI21/00084 FIS) and a grant from Health Research Institute Valdecilla (INNVAL21/24). N.M-B. is supported by Spanish Health Ministry or Spanish Ministeiro de Sanidad (PI21/01126). M.J.F.-G. is supported by Spanish Health Ministry or Spanish Ministerio de Sanidad contract (FIS22/00140). J.M.R. has received funding from La Caixa Foundation (HR18-00068); Spanish Ministerio de Ciencia e Innovación grant PID2021-122388OB-100 funded by MCIN/AEI/10.13039/501100011033; and Instituto de Salud Carlos III (CIBER-CV CB16/11/00264); Fundació La Marató TV3 grant 202334-31, and Spanish Ministerio de Ciencia e Innovación contract FPI (BES-2016-077649) to M.J.R.-R. The CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO is a Severo Ochoa Centers of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inflammageing, a targetable pathway for preventing cardiovascular diseases

  • Aranda, Juan Francisco
  • Ramírez, Cristina M
  • Mittelbrunn, María
Inflammageing, characterized by persistent chronic inflammation in older adults, has emerged as a critical factor linked to age-related diseases, such as cardiovascular diseases (CVDs), metabolic disorders, and cognitive decline, which collectively contribute to the leading causes of death globally. Elevated levels of cytokines, chemokines, and other inflammatory mediators characterize inflammageing and serve as indicators of biological age. Among the causes of inflammageing, deterioration of the immune system, mitochondrial dysfunction, dysbiosis, accumulation of DAMPs, together with genetic or epigenetic factors, contribute to inflammageing not only in CVD but also in other age-related conditions. This review examines the causes and consequences of inflammageing, particularly its implications for atherosclerosis and heart failure with preserved ejection fraction and explores potential strategies to mitigate it in the onset of CVD., This work was funded/co-funded by the European Union (ERC, Let T Be, ERC-2021-CoG 101044248). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. This work was funded/co-funded by Grant PID2022 1411690B-100 funded by MICIU/AEI/10.13039/501100011033 and, by ‘ESF Investing in your future’, Y2020/BIO-6350 NutriSION-CM synergy from Comunidad de Madrid (Spain) grants to M.M. and by PID2021-128264OB-I00 funded by MCIN/AEI/10.13039/501100011033 and ‘ERDF A way of making Europe’ by the European Union to C.M.R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging

  • Soto-Heredero, Gonzalo
  • Gabandé-Rodríguez, Enrique
  • Carrasco, Elisa
  • Escrig-Larena, José Ignacio
  • Gómez de las Heras, Manuel M.
  • Delgado-Pulido, Sandra
  • Francos-Quijorna, Isaac
  • Blanco, Eva M.
  • Fernández-Almeida, Álvaro
  • Abia, David
  • Rodríguez, María Josefa
  • Fernández-Díaz, Cristina M.
  • Álvarez-Flores, María Beatriz
  • Ramírez de Molina, Ana
  • Jung, Sascha
  • del Sol, Antonio
  • Zorita, Virginia
  • Sánchez-Cabo, Fátima
  • Torroja, Carlos
  • Mittelbrunn, María
Recent studies using single-cell RNA sequencing technology have uncovered several subpopulations of CD4 T cells that accumulate with aging. These age-associated T cells are emerging as relevant players in the onset of inflammaging and tissue senescence. Here, based on information provided by single-cell RNA sequencing data, we present a flow cytometry panel that allows the identification of age-associated T cell subsets in systematic larger analysis in mice. We use this panel to evaluate at the single-cell level mitochondrial and senescence marks in the different age-associated CD4 T cell subpopulations. Our analysis identifies a subpopulation of regulatory T (T) cells that is characterized by the extracellular expression of the co-inhibitory molecule killer cell lectin-like receptor subfamily G member 1 (KLRG1) and accumulates with aging in humans and mice. KLRG1-expressing T cells display senescence features such as mitochondrial alterations, increased expression of cell-cycle regulators and genomic DNA damage. Functionally, KLRG1 T cells show a reduced suppressive activity in vivo accompanied by a pro-inflammatory phenotype., This study was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe, and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). GENYAL Clinical Trials Platform of IMDEA Alimentación led by A. Ramírez de Molina and R. Ramos Ruiz conducted the volunteer recruitment and human clinical trial. Flow cytometry of human samples was conducted by Flow Cytometry Unit, CNIC, being the cytometer part of the grant EQC2018-005009-P funded by MCIN/AEI/10.13039/501100011033 and by ‘ERDF A way of making Europe’. G.S.-H. is supported by a FPI-UAM grant (Universidad Autónoma de Madrid). E.G.-R. was funded by a Juan de la Cierva grant (IJC2018-036850-I; Universidad Autónoma de Madrid). M.G. and J.I.E.-L. are supported by FPU grants (FPU19/02576 and FPU20/04066, respectively), both from Ministerio de Ciencia, Innovación y Universidades (Spain). E.C. is supported by SI4/PJI/2024-00166 from Comunidad de Madrid and UAM (Spain). S.D.-P. was funded by a PIPF grant (PIPF-2022/SAL-GL-25208), from Comunidad de Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Butyrate extends health and lifespan in mice with mitochondrial deficiency

  • Gabandé-Rodríguez, Enrique
  • Gómez de las Heras, Manuel M.
  • Ramírez-Ruiz de Erenchun, Pablo
  • Simó, Carolina
  • García-Cañas, Virginia
  • Inohara, Naohiro
  • Berenguer-López, Inés
  • Enríquez-Zarralanga, Violeta
  • Fernández-Almeida, Álvaro
  • Oller, Jorge
  • Soto-Heredero, Gonzalo
  • Carrasco, Elisa
  • Vázquez-Muñoz, Cristina
  • Delgado-Pulido, Sandra
  • Escrig-Larena, Jose Ignacio
  • Francos-Quijorna, Isaac
  • Justo-Méndez, Raquel
  • Aranda, Juan Francisco
  • Poulton, Joanna
  • Lechuga-Vieco, Ana Victoria
  • Enríquez, José Antonio
  • Núñez, Gabriel
  • Mittelbrunn, María
[Data availability] Ileum RNA-sequencing raw data, as well as microbiota 16S rRNA gene sequencing raw data, are publicly available via NCBI with BioProject numbers PRJNA1301342 and PRJNA1291203, respectively., Mitochondrial diseases progressively lead to multisystemic failure with treatment options remaining extremely limited. Here, to investigate strategies that alleviate mitochondrial dysfunction, we first generate a ubiquitous and tamoxifen-inducible knockout mouse model of mitochondrial transcription factor A (TFAM), a nuclear-encoded protein involved in mitochondrial DNA (mtDNA) maintenance — Tfamfl/flUbcCre-ERT2 (iTfamKO) mice. Systemic TFAM deficiency triggers mitochondrial decline in a myriad of tissues in adult mice. Consequently, iTfamKO mice manifest multiorgan dysfunction including lipodystrophy, sarcopenia, metabolic alterations, kidney failure, neurodegeneration, and locomotor dysregulation, which result in the premature death of these mice. Interestingly, iTfamKO mice display intestinal barrier disruption and gut dysbiosis, with diminished levels of microbiota-derived short-chain fatty acids (SCFAs), such as butyrate. Mice with a deficient proof-reading version of the mtDNA polymerase gamma (mtDNA-mutator mice) phenocopy the dysfunction of the intestinal barrier and bacterial dysbiosis with reduced levels of butyrate, suggesting that different mouse models of mitochondrial dysfunction share insufficient generation of butyrate. Transfer of microbiota from healthy control mice or administration of tributyrin, a butyrate precursor, delay multiple signs of multimorbidity, extending lifespan in iTfamKO mice. Mechanistically, butyrate supplementation recovers epigenetic histone acylation marks that are lost in the intestine of Tfam deficient mice. Overall, our findings highlight the relevance of preserving host-microbiota symbiosis in disorders related to mitochondrial dysfunction., We thank the Oxford Hospitals charity and Lily Foundation “Treatments for Mitochondrial Disease – 2019/20” (J.P.), Fundación Ramón Areces and MINECO through the Centers of Excellence Severo Ochoa Award, and CERCA Programme of the Generalitat de Catalunya (A.V.L.-V.). Funded by the European Union (M.M.). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This research was supported by a European Research Council grant ERC-2021-CoG 101044248-Let T Be (M.M.), Comunidad de Madrid (Spain) grant Y2020/BIO-6350 NutriSION-CM synergy (E.C. and M.M.), Spanish Ministerio de Ciencia e Innovación grant PID2022-141169OB-I00 (M.M.), Comunidad de Madrid (Spain) – Universidad Autónoma de Madrid (UAM) grant SI4/PJI/2024-00166 (E.C.), NIH grant R01 DK095782 (G.N.), Ministerio de Ciencia, Innovación y Universidades (Spain) FPU grants FPU19/02576 (M.M.G.H.), FPU24/02492 (P.R.-R.) and FPU20/04066 (J.I.E.-L.), Comunidad de Madrid (Spain) PIPF grant PIPF-2022/SAL-GL-25208 (S.D.-P.), Universidad Autónoma de Madrid FPI-UAM grant (G.S.-H.), and Ministerio de Ciencia, Innovación y Universidades (Spain) Juan de la Cierva-Incorporación grants IJC2018-036850-I (E.G.-R.) and JC2020-044392-I (I.F.-Q.)., Peer reviewed